Enzo Biochem, Inc. (NYSE:ENZ – Get Free Report) announced a quarterly dividend on Tuesday, October 29th, NASDAQ reports. Investors of record on Friday, November 15th will be paid a dividend of 0.10 per share by the medical research company on Monday, December 2nd. This represents a $0.40 dividend on an annualized basis and a yield of 34.48%. The ex-dividend date is Friday, November 15th.
Enzo Biochem Stock Up 2.7 %
NYSE:ENZ opened at $1.16 on Thursday. Enzo Biochem has a twelve month low of $0.99 and a twelve month high of $1.50. The business has a 50 day moving average price of $1.13 and a two-hundred day moving average price of $1.11.
Analyst Ratings Changes
Separately, StockNews.com assumed coverage on shares of Enzo Biochem in a report on Wednesday. They set a “hold” rating for the company.
Enzo Biochem Company Profile
Enzo Biochem, Inc develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis.
Further Reading
- Five stocks we like better than Enzo Biochem
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Silver Stocks, ETFs, or Bullion: What’s the Best Bet Now?
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Applied Materials vs ASML: Which is the Best Chip Stock to Own?
- Transportation Stocks Investing
- Top Bill Gates Stock Picks Every Investor Should Know About
Receive News & Ratings for Enzo Biochem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enzo Biochem and related companies with MarketBeat.com's FREE daily email newsletter.